Tradestie Institutional Equity Comparison Engine

PLUR vs SRZN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRZN Overall Edge

SRZN Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Surrozen, Inc. Common (SRZN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PLUR counters with relative strength in Valuation. Fundamentally, PLUR trades at 3.6x Forward P/E with -2454.5% operating margin (-15.8% YoY revenue) versus SRZN at N/M Forward P/E and -485.4% operating margin (+408.6% YoY). In options structure, PLUR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PLUR
PLUR 3.6x vs SRZN N/M Fwd P/E
Growth & Margin Winner SRZN
Op Margin -2454.5% vs -485.4% ยท YoY -15.8% vs +408.6%
Momentum & Technical Winner SRZN
1Y -78.0% vs +132.4% ยท 52W Pos 3% vs 70%
Options & Structure Winner SRZN
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (5th %ile IV)
PLUR US Equity
Pluri Inc.
Biological Products, (No Diagnostic Substances)
$0.98
-5.88% 1D
Market Cap $15.1M
1M Return +15.14%
1Y Return -78.0%
Forward P/E 3.6x
Unified AI Score
28.8 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0
SRZN NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$30.16
-6.68% 1D
Market Cap $602.5M
1M Return +26.51%
1Y Return +132.36%
Forward P/E N/M
Unified AI Score
33.2 / 100 SELL
Tech 50.0 Fund 34.0 Flow 65.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PLUR -78.0% SRZN +132.36% Spread: +207.0 pp (SRZN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PLUR Revenue SRZN Revenue PLUR Op. Margin SRZN Op. Margin Margin Edge
FY2018 $0M N/A -67462.0% N/A PLUR
FY2019 $0M N/A -65800.0% N/A PLUR
FY2020 $0M N/A -128156.5% N/A PLUR
FY2022 $0M $10M -17774.8% -354.7% SRZN
FY2023 $0M N/A -9493.4% N/A PLUR
FY2024 $0M $10M -6796.9% -239.7% SRZN
FY2025 $0M $0M -1659.9% -1210.6% SRZN
FY2026 $0M N/A -2454.5% N/A PLUR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PLUR (2) vs SRZN (7)
Institutional Metric PLUR SRZN Criterion Row Winner
Market Capitalization Scale $15.1M $602.5M Larger Scale SRZN
Trailing P/E Ratio Valuation 3.6x N/M Lower Multiple PLUR
Forward P/E Ratio Valuation 3.6x N/M Lower Multiple PLUR
Revenue Growth (YoY) Growth -15.8% +408.6% Higher Growth SRZN
Operating Margin (TTM) Profitability -2454.5% -485.4% Higher Margin SRZN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1022.0% -62.8% Higher ROE SRZN
52-Week Range Position Momentum 3% ($1โ€“$5) 70% ($12โ€“$38) Stronger Trend SRZN
Beta / 30D Volatility Risk Regime 0.79ฮฒ ยท 102% Vol 1.28ฮฒ ยท 70% Vol Lower Realized Risk SRZN
Unified Institutional Score Composite Signal 28.8 / 100 (SELL) 33.2 / 100 (SELL) Higher Composite SRZN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PLUR vs SRZN Buy Guide
PLUR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PLUR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SRZN CONSOLIDATION
38d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SRZN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PLUR nor SRZN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.